1. Roughley PJ, Mort JS. 2014. The role of aggrecan in normal and osteoarthritic cartilage. J Exp Orthop 1:8.
2. Knudson W, Ishizuka S, Terabe K, et al. 2019. The peri- cellular hyaluronan of articular chondrocytes. Matrix Biol 78‐79:32–46.
3. Ishizuka S, Askew EB, Ishizuka N, et al. 2016. 4‐methylumbelliferone diminishes catabolically activated articular chondrocytes and cartilage explants via a mecha- nism independent of hyaluronan inhibition. J Biol Chem 291: 12087–12104.
4. Ishizuka S, Tsuchiya S, Ohashi Y, et al. 2019. Hyaluronan synthase 2 (HAS2) overexpression diminishes the procata- bolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan. J Biol Chem 294:13562–13579.
5. Goldring MB. 2000. The role of the chondrocyte in osteo- arthritis. Arthritis Rheum 43:1916–1926.
6. Liu‐Bryan R, Terkeltaub R. 2015. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11:35–44.
7. Sandy JD, Chan DD, Trevino RL, et al. 2015. Human genome‐ wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis. Osteoarthr Cartilage 23:1939–1945.
8. Dunn SL, Soul J, Anand S, et al. 2016. Gene expression changes in damaged osteoarthritic cartilage identify a sig- nature of non‐chondrogenic and mechanical responses. Osteoarthr Cartilage 24:1431–1440.
9. Glasson SS, Blanchet TJ, Morris EA. 2007. The surgical destabilization of the medial meniscus (DMM) model of os- teoarthritis in the 129/SvEv mouse. Osteoarthr Cartilage 15: 1061–1069.
10. Culley KL, Dragomir CL, Chang J, et al. 2015. Mouse models of osteoarthritis: surgical model of posttraumatic osteo- arthritis induced by destabilization of the medial meniscus. Methods Mol Biol 1226:143–173.
11. Ratneswaran A, Beier F. 2017. An approach towards accountability: suggestions for increased reproducibility in surgical destabilization of medial meniscus (DMM) models. Osteoarthritis Cartilage 25:1747–1750.
12. Yoshioka Y, Kozawa E, Urakawa H, et al. 2013. Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibro- blasts. Arthritis Rheum 65:1160–1170.
13. Nagy N, Kuipers HF, Frymoyer AR, et al. 2015. 4‐methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol 6:123.
14. Kakizaki I, Kojima K, Takagaki K, et al. 2004. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4‐methylumbelliferone. J Biol Chem 279:33281–33289.
15. Vigetti D, Ori M, Viola M, et al. 2006. Molecular cloning and characterization of UDP‐glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J Biol Chem 281:8254–8263.
16. Hascall VC, Wang A, Tammi M, et al. 2014. The dynamic metabolism of hyaluronan regulates the cytosolic concen- tration of UDP‐GlcNAc. Matrix Biol 35:14–17.
17. Kultti A, Pasonen‐Seppänen S, Jauhiainen M, et al. 2009. 4‐Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP‐glucuronic acid and down- regulation of hyaluronan synthase 2 and 3. Exp Cell Res 315:1914–1923.
18. Chanmee T, Ontong P, Izumikawa T, et al. 2016. Hyaluronan production regulates metabolic and cancer stem‐like properties of breast cancer cells via hexosamine biosynthetic pathway‐coupled HIF‐1 signaling. J Biol Chem 291:24105–24120.
19. Nagy N, de la Zerda A, Kaber G, et al. 2018. Hyaluronan content governs tissue stiffness in pancreatic islet inflammation. J Biol Chem 293:567–578.
20. Nagy N, Freudenberger T, Melchior‐Becker A, et al. 2010. Inhibition of hyaluronan synthesis accelerates murine athe- rosclerosis: novel insights into the role of hyaluronan syn- thesis. Circulation 122:2313–2322.
21. Kuipers HF, Nagy N, Ruppert SM, et al. 2016. The pharma-cokinetics and dosing of oral 4‐methylumbelliferone for inhibition of hyaluronan synthesis in mice. Clin Exp Immunol 185:372–381.
22. Ulici V, Kelley KL, Azcarate‐Peril MA, et al. 2018. Osteo- arthritis induced by destabilization of the medial meniscus is reduced in germ‐free mice. Osteoarthr Cartilage 26: 1098–1109.
23. Rowe MA, Harper LR, McNulty MA, et al. 2017. Reduced osteoarthritis severity in aged mice with deletion of macro- phage migration inhibitory factor. Arthritis Rheumatol 69: 352–361.
24. Pritzker KPH, Gay S, Jimenez SA, et al. 2006. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartilage 14:13–29.
25. Takahashi N, Knudson CB, Thankamony S, et al. 2010. Induction of CD44 cleavage in articular chondrocytes. Ar- thritis Rheum 62:1338–1348.
26. Farndale RW, Sayers CA, Barrett AJ. 1982. A direct spec- trophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9:247–248.
27. Ariyoshi W, Knudson CB, Luo N, et al. 2010. Internalization of aggrecan G1 domain neoepitope ITEGE in chondrocytes requires CD44. J Biol Chem 285:36216–36224.
28. Urakawa H, Nishida Y, Wasa J, et al. 2012. Inhibition of hyaluronan synthesis in breast cancer cells by 4‐methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Int J Cancer 130: 454–466.
29. Ikuta K, Ota T, Zhuo L, et al. 2017. Antitumor effects of 4‐methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor. Int J Cancer 140: 469–479.
30. Mueller AM, Yoon BH, Sadiq SA. 2014. Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS. J Biol Chem 289: 22888–22899.
31. Ma HL, Blanchet TJ, Peluso D, et al. 2007. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteo- arthr Cartilage 15:695–700.
32. Terabe K, Ohashi Y, Tsuchiya S, et al. 2019. Chondroprotective effects of 4‐methylumbelliferone and hyaluronan synthase‐2 over‐expression involve changes in chondrocyte energy metabo- lism. J Biol Chem 294:17799–17817.